rs771063151

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_001190787.3(MCIDAS):​c.218-13_218-6dupTCTCCCCG variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000724 in 1,499,124 control chromosomes in the GnomAD database, including 5 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00049 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00075 ( 5 hom. )

Consequence

MCIDAS
NM_001190787.3 splice_region, intron

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.252

Publications

0 publications found
Variant links:
Genes affected
MCIDAS (HGNC:40050): (multiciliate differentiation and DNA synthesis associated cell cycle protein) This gene encodes a member of the geminin family of proteins. The encoded nuclear protein is required for the generation of multiciliated cells in respiratory epithelium. Mutations in this gene cause a rare mucociliary clearance disorder associated with recurring respiratory infections in human patients, known as reduced generation of multiple motile cilia (RGMC). [provided by RefSeq, Sep 2016]
MCIDAS Gene-Disease associations (from GenCC):
  • ciliary dyskinesia, primary, 42
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 5-55226672-G-GCGGGGAGA is Benign according to our data. Variant chr5-55226672-G-GCGGGGAGA is described in ClinVar as Likely_benign. ClinVar VariationId is 454527.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000492 (75/152314) while in subpopulation SAS AF = 0.00145 (7/4830). AF 95% confidence interval is 0.000679. There are 0 homozygotes in GnomAd4. There are 37 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MCIDASNM_001190787.3 linkc.218-13_218-6dupTCTCCCCG splice_region_variant, intron_variant Intron 2 of 6 ENST00000513312.3 NP_001177716.1
LOC124900978XR_007058773.1 linkn.57_64dupGGGGAGAC non_coding_transcript_exon_variant Exon 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MCIDASENST00000513312.3 linkc.218-6_218-5insTCTCCCCG splice_region_variant, intron_variant Intron 2 of 6 1 NM_001190787.3 ENSP00000426359.1
MCIDASENST00000513468.5 linkn.218-6_218-5insTCTCCCCG splice_region_variant, intron_variant Intron 2 of 6 5 ENSP00000422165.1
MCIDASENST00000515336.1 linkn.155-6_155-5insTCTCCCCG splice_region_variant, intron_variant Intron 2 of 5 5

Frequencies

GnomAD3 genomes
AF:
0.000493
AC:
75
AN:
152196
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000750
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000357
AC:
35
AN:
97914
AF XY:
0.000389
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000237
Gnomad NFE exome
AF:
0.000591
Gnomad OTH exome
AF:
0.000669
GnomAD4 exome
AF:
0.000750
AC:
1010
AN:
1346810
Hom.:
5
Cov.:
31
AF XY:
0.000775
AC XY:
513
AN XY:
662288
show subpopulations
African (AFR)
AF:
0.000102
AC:
3
AN:
29368
American (AMR)
AF:
0.0000663
AC:
2
AN:
30146
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23272
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32870
South Asian (SAS)
AF:
0.000790
AC:
59
AN:
74638
European-Finnish (FIN)
AF:
0.0000906
AC:
3
AN:
33128
Middle Eastern (MID)
AF:
0.000401
AC:
2
AN:
4984
European-Non Finnish (NFE)
AF:
0.000850
AC:
903
AN:
1062308
Other (OTH)
AF:
0.000677
AC:
38
AN:
56096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000492
AC:
75
AN:
152314
Hom.:
0
Cov.:
33
AF XY:
0.000497
AC XY:
37
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41592
American (AMR)
AF:
0.000457
AC:
7
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4830
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000750
AC:
51
AN:
68020
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000480
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:1
Dec 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MCIDAS-related disorder Benign:1
May 19, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Ciliary dyskinesia, primary, 42 Benign:1
Feb 24, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.25

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs771063151; hg19: chr5-54522500; API